Pharma Co. Beats Investor Suit Over Licensing Agreement
By Sydney Price · February 9, 2024, 8:37 PM EST
A New York federal judge has dismissed a proposed investor class action against pharmaceutical company Molecular Partners, ruling the plaintiff failed to show the company misled investors about its progress in...
To view the full article, register now.